Carol A. Surface - 02 Aug 2021 Form 4 Insider Report for Medtronic plc (MDT)

Role
SVP, Chief HR Officer
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
02 Aug 2021
Net transactions value
-$524,846
Form type
4
Filing time
04 Aug 2021, 18:25:45 UTC
Next filing
14 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Tax liability $524,846 -3,997 -12% $131.31 30,670 02 Aug 2021 Direct F1
transaction MDT Ordinary Shares Award $0 +3,657 +12% $0.000000 34,327 02 Aug 2021 Direct F2
holding MDT Ordinary Shares 567 02 Aug 2021 NQ Ret Plan Sup F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Stock Option (Right to Buy) Award $0 +31,245 $0.000000 31,245 02 Aug 2021 Ordinary Shares 31,245 $131.26 Direct F4
transaction MDT Stock Option (Right to Buy) Award $0 +1,085 $0.000000 1,085 02 Aug 2021 Ordinary Shares 1,085 $131.26 Direct F4
transaction MDT Performance Share Units Award $0 +9,143 $0.000000 9,143 02 Aug 2021 Performance Share Units 9,143 Direct F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This balance increased by 517 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan.
F2 The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
F3 Between December 28, 2020 and June 30, 2021, the reporting person acquired 8 shares of MDT common stock under the Medtronic NQ Retirement Plan. The information in this report is based on a statement dated as of June 30, 2021.
F4 These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
F5 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F6 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,143 shares will be issued. The actual number of shares to be issued could range from a low of 1,829 at minimum performance to a high of 18,286 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F7 Vests on August 2, 2024.